CN1917875A - 治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合 - Google Patents

治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合 Download PDF

Info

Publication number
CN1917875A
CN1917875A CNA2005800044314A CN200580004431A CN1917875A CN 1917875 A CN1917875 A CN 1917875A CN A2005800044314 A CNA2005800044314 A CN A2005800044314A CN 200580004431 A CN200580004431 A CN 200580004431A CN 1917875 A CN1917875 A CN 1917875A
Authority
CN
China
Prior art keywords
alkyl
group
alternatively
phenyl
perhaps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800044314A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·费尔赫斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN1917875A publication Critical patent/CN1917875A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2005800044314A 2004-02-09 2005-02-08 治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合 Pending CN1917875A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402797.5A GB0402797D0 (en) 2004-02-09 2004-02-09 Organic compounds
GB0402797.5 2004-02-09

Publications (1)

Publication Number Publication Date
CN1917875A true CN1917875A (zh) 2007-02-21

Family

ID=31985893

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800044314A Pending CN1917875A (zh) 2004-02-09 2005-02-08 治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合

Country Status (13)

Country Link
EP (1) EP1715860A1 (https=)
JP (1) JP2007522141A (https=)
KR (1) KR20060127974A (https=)
CN (1) CN1917875A (https=)
AR (1) AR047962A1 (https=)
AU (1) AU2005210140A1 (https=)
BR (1) BRPI0507544A (https=)
CA (1) CA2552938A1 (https=)
GB (1) GB0402797D0 (https=)
PE (1) PE20050692A1 (https=)
RU (1) RU2006132195A (https=)
TW (1) TW200536533A (https=)
WO (1) WO2005074924A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702456D0 (en) * 2007-02-08 2007-03-21 Astrazeneca Ab New combination
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2011534A1 (en) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Metered dose inhaler actuator
JP4686650B2 (ja) 2007-11-30 2011-05-25 ファイザー・リミテッド 新規なグルココルチコイド受容体アゴニスト
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
MY194619A (en) 2016-06-02 2022-12-07 Abbvie Inc Glucocorticoid receptor agonist and immunoconjugates thereof
AU2018374634A1 (en) 2017-12-01 2020-05-28 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (en) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha BENZOTHIAZOLONE DERIVATIVES HAVING SELECTIVE β2 RECEPTOR AGONIST ACTIVITY
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos

Also Published As

Publication number Publication date
BRPI0507544A (pt) 2007-06-12
EP1715860A1 (en) 2006-11-02
AR047962A1 (es) 2006-03-15
KR20060127974A (ko) 2006-12-13
RU2006132195A (ru) 2008-03-20
WO2005074924A1 (en) 2005-08-18
TW200536533A (en) 2005-11-16
JP2007522141A (ja) 2007-08-09
PE20050692A1 (es) 2005-11-15
CA2552938A1 (en) 2005-08-18
GB0402797D0 (en) 2004-03-10
AU2005210140A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
CN1917875A (zh) 治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合
CN1212119C (zh) 有机化合物
CN1213047C (zh) 酪氨酸蛋白激酶syk的嘌呤衍生物抑制剂
CN1178912C (zh) 旋转异构酶活性的小分子抑制剂
JP5567252B2 (ja) グリコピロレートおよびベータ２アドレナリン受容体アゴニストの組合せ剤
CN1933834A (zh) 吲唑甲酰胺衍生物在制备用于治疗和预防疟疾的药物中的用途
HK1054232A1 (zh) 用作pde4同工酶抑制剂的嘧啶甲酰胺
CN101056634A (zh) 奎宁环衍生物及它们作为毒蕈碱m3受体拮抗剂的用途
CN1487938A (zh) 新的奎宁环衍生物类及含有这类衍生物的药物组合物
CN1816549A (zh) 磷脂酰肌醇3－激酶抑制剂
CN1950323A (zh) Crth2受体拮抗剂
CN1930125A (zh) 适用作毒蕈碱性受体拮抗剂的联苯基化合物
CN1382141A (zh) 1,8－二氮杂萘衍生物
JP2008525359A (ja) Ｍ３アンタゴニストとしての第４級アンモニウム塩類
CN1617743A (zh) 用于一氧化氮合酶抑制剂的新药物联合应用
CN1860113A (zh) 用作pde4抑制剂的烟酰胺衍生物
CN101087777B (zh) 作为m3毒蕈碱受体的吡咯烷衍生物
HK1038751A1 (zh) 具有止喘、抗變態反應、抗炎、免疫調節和神經保護作用的新的1，2，5-三取代1，2-二氫吲唑-3-酮類化合物、其製備方法以及作為藥物的應用
HK1040706A1 (zh) Fkbp抑制剂
CN1942463A (zh) 2－氨基嘧啶衍生物
CN1121398C (zh) 脂环式酰化杂环衍生物
JP6502469B2 (ja) 化合物
CN1713909A (zh) 氨基吲唑衍生物及其作为激酶抑制剂的用途
CN1301980C (zh) 具有β2－肾上腺素受体激动剂活性的苯并噻唑衍生物
CN1930148A (zh) 2 , 5－二甲基－2h－吡唑－3－羧酸{2－氟－5－[3－((e)－2－吡啶－2－基－乙烯基)－1h－吲唑－6－基氨基]－苯基}－酰胺的多晶型物和非晶物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication